What Omada Health's FY2025 10-K says: 12 signals
Omada Health filed its latest 10-K with the SEC on Mar 6, 2026. It discusses product launch, AI investment and audit issue.
Public (OMDA)Hospitals and Health Care1,001 to 5,000 employeesomadahealth.comLinkedIn
- Filed
- Mar 6, 2026
- Period
- FY2025
- Fiscal year end
- 12/31
- Filings
- 1
10-K · latest 10
What Omada Health's 10-K filings say
- SEC EDGAR
10-K · FY2025
Filed · Fiscal year ends 12/31 · 12 signals
Omada Health identifies material weakness in internal control over financial reporting
This could involve new GRC software, consulting services, or process overhauls to regain investor confidence and ensure accurate reporting.
Launching new GLP-1 prescribing and medication management capability in the current year.
Omada is expanding its GLP-1 support to include prescribing and medication management via licensed providers.
Omada Health launched "OmadaSpark" AI agent and uses AI/ML for personalized care.
The company is actively deploying AI and machine learning to interpret vast amounts of patient data (over 75,000 data points per minute) to personalize care and improve efficiency.
AImachine learning
The company's arrangements with clinical partners like Physera Physical Therapy Group (PPTG) are subject to complex state laws, creating risk of penalties and restructuring.
Physera Physical Therapy Group, PC
Planning commercial launch of new Cholesterol program in 2026, with broad launch in 2027.
The company is expanding its cardiometabolic platform with a new program for high cholesterol, building on its existing offerings.
Rapid growth is forcing investment to rework and expand existing technology systems.
The company's rapid growth has strained its current technology infrastructure, creating an explicit need to invest significant resources in reworking existing systems.
Omada depends on limited third-party suppliers for connected devices and cellular connectivity
The company's reliance on a few suppliers for critical components like medical devices and IoT connectivity creates supply chain risk.
cellular-connected
The company's growth trajectory requires a significant increase in the size of its organization, particularly its specialized Care Teams, and they identify attracting and retaining talent as a key business risk.
Expanding platform to cover multiple chronic conditions including MSK, Hypertension, and Diabetes.
Omada is executing a multi-condition platform strategy, expanding beyond its original diabetes prevention program to address musculoskeletal (MSK), hypertension, and diabetes management.
Physera Physical Therapy Group, PC
Data platform processes over 75,000 data points per minute from connected devices.
Omada's platform ingests a massive volume of real-time data from member interactions and connected devices, indicating a significant investment in data capture, storage, and analytics infrastructure.
Showing 10 of 12 filing signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Omada Health with the Signal API
One POST /v1/companies/enrich call with omadahealth.com returns Omada Health 10-K signals (sec-10k), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"omadahealth.com","signal_types":["sec-10k"],"limit":20}'Same industry
10-K at related companies
Questions about Omada Health 10-K
When did Omada Health file its latest 10-K?
What does Omada Health's latest 10-K say about audit issue?
Where can I find Omada Health's annual report?
Source. Annual reports (Form 10-K) filed with the SEC. Every card links to the filing on EDGAR.
Method. Insights are extracted from the filing text and grouped by category. Numbers are quoted from the filing.
Data as of .